The role of iron and reactive oxygen species in cell death

Nature Chemical Biology

Volumn 10, Issue 1, 2014, Pages 9-17

  Dixon, Scott J ^a,b   Stockwell, Brent R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; GLUTAMIC ACID; IRON; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; WATER;

APOPTOSIS; CELL DEATH; CELL GROWTH; CELL VIABILITY; DEGENERATIVE DISEASE; EXCITOTOXICITY; GENETIC DISORDER; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; LYSOSOME; MALIGNANT NEOPLASTIC DISEASE; MEDIATOR; MITOCHONDRION; NECROPTOSIS; NECROSIS; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW;

CELL DEATH; HUMANS; IRON; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84890922670     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1416     Document Type: Review

References (103)

1. Frey, P.A. & Reed, G.H. The ubiquity of iron. ACS Chem. Biol. 7, 1477-1481(2012).
2. Lambeth, J.D. & Neish, A.S. Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu. Rev. Pathol. doi:10.1146/ annurev-pathol-012513-104651(2013).
3. Kell, D.B. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genomics 2, 2(2009).
4. Petrat, F., de Groot, H., Sustmann, R. & Rauen, U. The chelatable iron pool in living cells: a methodically defined quantity. Biol. Chem. 383, 489-502(2002). (Pubitemid 34506286)
5. Kurz, T., Eaton, J.W. & Brunk, U.T. The role of lysosomes in iron metabolism and recycling. Int. J. Biochem. Cell Biol. 43, 1686-1697(2011).
6. Carlioz, A. & Touati, D. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? EMBO J. 5, 623-630(1986).
7. Imlay, J.A. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat. Rev. Microbiol. 11, 443-454(2013).
8. Flint, D.H., Tuminello, J.F. & Emptage, M.H. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J. Biol. Chem. 268, 22369-22376(1993). (Pubitemid 23318282)
9. Esposito, L.A., Melov, S., Panov, A., Cottrell, B.A. & Wallace, D.C. Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 96, 4820-4825(1999). (Pubitemid 29214495)
10. Melov, S. et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA 96, 846-851(1999). (Pubitemid 29072146)
11. Li, Y. et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11, 376-381(1995).
12. Brennan, A.M. et al. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 12, 857-863(2009).
13. Farrow, M.A. et al. Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proc. Natl. Acad. Sci. USA 110, 18674-18679(2013).
14. Seaver, L.C. & Imlay, J.A. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. J. Bacteriol. 183, 7173-7181(2001). (Pubitemid 33121851)
15. Park, S., You, X. & Imlay, J.A. Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpx- mutants of Escherichia coli. Proc. Natl. Acad. Sci. USA 102, 9317-9322(2005). (Pubitemid 40923561)
16. Jang, S. & Imlay, J.A. Micromolar intracellular hydrogen peroxide disrupts metabolism by damaging iron-sulfur enzymes. J. Biol. Chem. 282, 929-937(2007). (Pubitemid 47076541)
17. Jang, S. & Imlay, J.A. Hydrogen peroxide inactivates the Escherichia coli Isc iron-sulphur assembly system, and OxyR induces the Suf system to compensate. Mol. Microbiol. 78, 1448-1467(2010).
18. Anjem, A. & Imlay, J.A. Mononuclear iron enzymes are primary targets of hydrogen peroxide stress. J. Biol. Chem. 287, 15544-15556(2012).
19. Sobota, J.M. & Imlay, J.A. Iron enzyme ribulose-5-phosphate 3-epimerase in Escherichia coli is rapidly damaged by hydrogen peroxide but can be protected by manganese. Proc. Natl. Acad. Sci. USA 108, 5402-5407(2011).
20. Cvetkovic, A. et al. Microbial metalloproteomes are largely uncharacterized. Nature 466, 779-782(2010).
21. Antunes, F., Cadenas, E. & Brunk, U.T. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. Biochem. J. 356, 549-555(2001). (Pubitemid 32532368)
22. Hamacher-Brady, A. et al. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J. Biol. Chem. 286, 6587-6601(2011).
23. Seiler, A. et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8, 237-248(2008).
24. Heo, J.M. et al. A stress-responsive system for mitochondrial protein degradation. Mol. Cell 40, 465-480(2010).
25. Madeo, F., Frohlich, E. & Frohlich, K.U. A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell Biol. 139, 729-734(1997). (Pubitemid 27486568)
26. Braun, R.J. et al. Crucial mitochondrial impairment upon CDC48 mutation in apoptotic yeast. J. Biol. Chem. 281, 25757-25767(2006). (Pubitemid 44401964)
27. Madeo, F. et al. Oxygen stress: a regulator of apoptosis in yeast. J. Cell Biol. 145, 757-767(1999). (Pubitemid 29240853)
28. Bartolome, F. et al. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron 78, 57-64(2013).
29. Raimundo, N. et al. Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness. Cell 148, 716-726(2012).
30. Chae, S. et al. A systems approach for decoding mitochondrial retrograde signaling pathways. Sci. Signal. 6, rs4(2013).
31. Kagan, V.E. et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1, 223-232(2005).
32. Ji, J. et al. Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat. Neurosci. 15, 1407-1413(2012).
33. Jiang, J. et al. Interplay between bax, reactive oxygen species production, and cardiolipin oxidation during apoptosis. Biochem. Biophys. Res. Commun. 368, 145-150(2008).
34. Ricci, J.E. et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117, 773-786(2004).
35. Huai, J. et al. TNFa-induced lysosomal membrane permeability (LMP) is downstream of MOMP and triggered by caspase-mediated p75 cleavage and ROS formation. J. Cell Sci. 126, 4015-4025(2013).
36. Garcia-Perez, C. et al. Bid-induced mitochondrial membrane permeabilization waves propagated by local reactive oxygen species (ROS) signaling. Proc. Natl. Acad. Sci. USA 109, 4497-4502(2012).
37. Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112-119(2005).
38. Linkermann, A. et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 110, 12024-12029(2013).
39. Zhang, D.W. et al. RIP3, an energy metabolism regulator that switches TNFinduced cell death from apoptosis to necrosis. Science 325, 332-336(2009).
40. Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485(1998). (Pubitemid 28215406)
41. Shulga, N. & Pastorino, J.G. GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J. Cell Sci. 125, 2995-3003(2012).
42. Kim, Y.S., Morgan, M.J., Choksi, S. & Liu, Z.G. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell 26, 675-687(2007). (Pubitemid 46856240)
43. Yazdanpanah, B. et al. Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature 460, 1159-1163(2009).
44. Xie, C. et al. Distinct roles of basal steady-state and induced H-ferritin in tumor necrosis factor-induced death in L929 cells. Mol. Cell. Biol. 25, 6673-6681(2005). (Pubitemid 41023240)
45. Dixon, S.J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072(2012).
46. Yagoda, N. et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864-868(2007). (Pubitemid 46920135)
47. Yang, W.S. & Stockwell, B.R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RASharboring cancer cells. Chem. Biol. 15, 234-245(2008). (Pubitemid 351391983)
48. Gout, P.W., Buckley, A.R., Simms, C.R. & Bruchovsky, N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc - cystine transporter: a new action for an old drug. Leukemia 15, 1633-1640(2001). (Pubitemid 32994684)
49. Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L. & Coyle, J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558(1989).
50. Wolpaw, A.J. et al. Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc. Natl. Acad. Sci. USA 108, E771-E780(2011).
51. Shaw, A.T. et al. Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc. Natl. Acad. Sci. USA 108, 8773-8778(2011).
52. Siddiq, A. et al. Selective inhibition of hypoxia-inducible factor (HIF) prolylhydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways. J. Neurosci. 29, 8828-8838(2009).
53. Li, Y., Maher, P. & Schubert, D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453-463(1997). (Pubitemid 27374242)
54. Abeysinghe, R.D. et al. The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelators. J. Biol. Chem. 271, 7965-7972(1996). (Pubitemid 26108614)
55. Tan, S., Schubert, D. & Maher, P. Oxytosis: A novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497-506(2001).
56. Zaman, K. et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci. 19, 9821-9830(1999). (Pubitemid 30226655)
57. Tan, S., Wood, M. & Maher, P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71, 95-105(1998). (Pubitemid 28292539)
58. Tobaben, S. et al. Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ. 18, 282-292(2011).
59. Henke, N. et al. The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell Death Dis. 4, e470(2013).
60. Volpe, J.J., Kinney, H.C., Jensen, F.E. & Rosenberg, P.A. The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int. J. Dev. Neurosci. 29, 423-440(2011).
61. Sato, H. et al. Distribution of cystine/glutamate exchange transporter, system xc -, in the mouse brain. J. Neurosci. 22, 8028-8033(2002). (Pubitemid 35379108)
62. Hentze, M.W., Muckenthaler, M.U., Galy, B. & Camaschella, C. Two to tango: regulation of mammalian iron metabolism. Cell 142, 24-38(2010).
63. Puccio, H. et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 27, 181-186(2001). (Pubitemid 32157445)
64. Eaton, J.W. & Qian, M. Molecular bases of cellular iron toxicity. Free Radic. Biol. Med. 32, 833-840(2002). (Pubitemid 34439254)
65. Silva-Gomes, S. et al. Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death. J. Hepatol. doi:10.1016/j.jhep.2013.09.004(2013).
66. Torti, S.V. & Torti, F.M. Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13, 342-355(2013).
67. Kruer, M.C. The neuropathology of neurodegeneration with brain iron accumulation. Int. Rev. Neurobiol. 110, 165-194(2013).
68. Lei, P. et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291-295(2012).
69. Duce, J.A. et al. Iron-export ferroxidase activity of b-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867(2010).
70. Kaur, D. et al. Genetic or pharmacological iron chelation prevents MPTPinduced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37, 899-909(2003). (Pubitemid 36398297)
71. Guzman, J.N. et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696-700(2010).
72. Allen, G.F., Toth, R., James, J. & Ganley, I.G. Loss of iron triggers PINK1/ Parkin-independent mitophagy. EMBO Rep. doi:10.1038/embor.2013.168(2013) .
73. Chen, Y. et al. Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity. J. Neurosci. 33, 3582-3587(2013).
74. Cheah, J.H. et al. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51, 431-440(2006). (Pubitemid 44209322)
75. Vaseva, A.V. et al. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149, 1536-1548(2012).
76. Zhang, X. & Lemasters, J.J. Translocation of iron from lysosomes to mitochondria during ischemia predisposes to injury after reperfusion in rat hepatocytes. Free Radic. Biol. Med. 63, 243-253(2013).
77. Uchiyama, A. et al. Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury. Hepatology 48, 1644-1654(2008).
78. Li, L., Chen, O.S., McVey Ward, D. & Kaplan, J. CCC1 is a transporter that mediates vacuolar iron storage in yeast. J. Biol. Chem. 276, 29515-29519(2001).
79. Lin, H., Li, L., Jia, X., Ward, D.M. & Kaplan, J. Genetic and biochemical analysis of high iron toxicity in yeast: iron toxicity is due to the accumulation of cytosolic iron and occurs under both aerobic and anaerobic conditions. J. Biol. Chem. 286, 3851-3862(2011).
80. Holmes-Hampton, G.P., Jhurry, N.D., McCormick, S.P. & Lindahl, P.A. Iron content of Saccharomyces cerevisiae cells grown under iron-deficient and iron-overload conditions. Biochemistry 52, 105-114(2013).
81. Li, L., Bagley, D., Ward, D.M. & Kaplan, J. Yap5 is an iron-responsive transcriptional activator that regulates vacuolar iron storage in yeast. Mol. Cell. Biol. 28, 1326-1337(2008). (Pubitemid 351214134)
82. Lee, Y.J. et al. Sphingolipid signaling mediates iron toxicity. Cell Metab. 16, 90-96(2012).
83. Breslow, D.K. et al. Orm family proteins mediate sphingolipid homeostasis. Nature 463, 1048-1053(2010).
84. Kelso, G.F. et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276, 4588-4596(2001).
85. McManus, M.J., Murphy, M.P. & Franklin, J.L. The mitochondria- targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 31, 15703-15715(2011).
86. Lowes, D.A., Webster, N.R., Murphy, M.P. & Galley, H.F. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br. J. Anaesth. 110, 472-480(2013).
87. Wipf, P. et al. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J. Am. Chem. Soc. 127, 12460-12461(2005). (Pubitemid 41292143)
88. Xun, Z. et al. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. Cell Rep. 2, 1137-1142(2012).
89. DeNicola, G.M. et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109(2011).
90. Son, J. et al. Glutamine supports pancreatic cancer growth through a KRASregulated metabolic pathway. Nature 496, 101-105(2013).
91. Maddocks, O.D. et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493, 542-546(2013).
92. Trachootham, D., Alexandre, J. & Huang, P. Targeting cancer cells by ROSmediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8, 579-591(2009).
93. Pei, S. et al. Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells. J. Biol. Chem. doi:10.1074/jbc. M113.511170(2013).
94. Trachootham, D. et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by b-phenylethyl isothiocyanate. Cancer Cell 10, 241-252(2006). (Pubitemid 44311067)
95. Raj, L. et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475, 231-234(2011).
96. Dolma, S., Lessnick, S.L., Hahn, W.C. & Stockwell, B.R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285-296(2003). (Pubitemid 37443883)
97. Diehn, M. et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780-783(2009).
98. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A. & Collins, J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810(2007). (Pubitemid 47332566)
99. Liu, Y. & Imlay, J.A. Cell death from antibiotics without the involvement of reactive oxygen species. Science 339, 1210-1213(2013).
100. Zhang, S. et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat. Med. 18, 1639-1642(2012).
101. Cochemé, H.M. et al. Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab. 13, 340-350(2011).
102. Albrecht, S.C., Barata, A.G., Grosshans, J., Teleman, A.A. & Dick, T.P. In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab. 14, 819-829(2011).
103. Au-Yeung, H.Y., Chan, J., Chantarojsiri, T. & Chang, C.J. Molecular imaging of labile iron(ii) pools in living cells with a turn-on fluorescent probe. J. Am. Chem. Soc. 135, 15165-15173(2013).